“Efficacy and Safety of Dapagliflozin As Adjunct Therapy in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea”. 2026. Academia Journal of Medicine 9 (2): 201-5. https://doi.org/10.48165/ajm.2026.9.02.34.